Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions 论文

2006Pharmacology & Therapeutics引用 572
Lipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyComputational Drug Discovery Methods

详细信息

发表期刊/会议
Pharmacology & Therapeutics
发表日期
2006-05-23
发表年份
2006

关键词

Lipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyComputational Drug Discovery Methods